| Literature DB >> 27746738 |
Christoph Zinner1, David Morales-Alamo2, Niels Ørtenblad3, Filip J Larsen4, Tomas A Schiffer5, Sarah J Willis6, Miriam Gelabert-Rebato2, Mario Perez-Valera2, Robert Boushel7, Jose A L Calbet8, Hans-Christer Holmberg9.
Abstract
To elucidate the mechanisms underlying the differences in adaptation of arm and leg muscles to sprint training, over a period of 11 days 16 untrained men performed six sessions of 4-6 × 30-s all-out sprints (SIT) with the legs and arms, separately, with a 1-h interval of recovery. Limb-specific VO2peak, sprint performance (two 30-s Wingate tests with 4-min recovery), muscle efficiency and time-trial performance (TT, 5-min all-out) were assessed and biopsies from the m. vastus lateralis and m. triceps brachii taken before and after training. VO2peak and Wmax increased 3-11% after training, with a more pronounced change in the arms (P < 0.05). Gross efficiency improved for the arms (+8.8%, P < 0.05), but not the legs (-0.6%). Wingate peak and mean power outputs improved similarly for the arms and legs, as did TT performance. After training, VO2 during the two Wingate tests was increased by 52 and 6% for the arms and legs, respectively (P < 0.001). In the case of the arms, VO2 was higher during the first than second Wingate test (64 vs. 44%, P < 0.05). During the TT, relative exercise intensity, HR, VO2, VCO2, VE, and Vt were all lower during arm-cranking than leg-pedaling, and oxidation of fat was minimal, remaining so after training. Despite the higher relative intensity, fat oxidation was 70% greater during leg-pedaling (P = 0.017). The aerobic energy contribution in the legs was larger than for the arms during the Wingate tests, although VO2 for the arms was enhanced more by training, reducing the O2 deficit after SIT. The levels of muscle glycogen, as well as the myosin heavy chain composition were unchanged in both cases, while the activities of 3-hydroxyacyl-CoA-dehydrogenase and citrate synthase were elevated only in the legs and capillarization enhanced in both limbs. Multiple regression analysis demonstrated that the variables that predict TT performance differ for the arms and legs. The primary mechanism of adaptation to SIT by both the arms and legs is enhancement of aerobic energy production. However, with their higher proportion of fast muscle fibers, the arms exhibit greater plasticity.Entities:
Keywords: high-intensity training; lower body; performance; triceps brachii; upper body
Year: 2016 PMID: 27746738 PMCID: PMC5043010 DOI: 10.3389/fphys.2016.00426
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Characteristics of the participants (means ± SD) before (pre) and after (post) the training intervention.
| Age (yrs) | 24 ± 4 | |
| Body mass (kg) | 77.8 ± 6.9 | 77.7 ± 6.8 |
| Total body lean mass (kg) | 60.9 ± 5.8 | 61.1 ± 5.8 |
| Percentage of fat mass for the entire body (%) | 18.1 ± 4.9 | 17.8 ± 4.7 |
| VO2peak (leg exercise) (L·min−1) | 3.9 ± 0.5 | 4.1 ± 0.5 |
| VO2peak (leg exercise) (mL·kg−1·min−1) | 48.7 ± 6.5 | 51.9 ± 7.2 |
P < 0.05 compared to the Pre-value.
Figure 1Schematic illustration of our experimental protocol. All testing and training was performed employing both leg-pedaling (left) and arm-cranking (right). The values in brackets indicate the number of 30-s sprints per training session.
Figure 2Results for the 16 subjects during the seven training sessions of leg-pedaling and arm-cranking. (A) Mean power output, (B) mean power output in relationship to order of training, (C) total work, and (D) total work in relationship to order of training.
Effects of six sessions of sprint interval training on ergospirometric variables and performance during incremental exercise to exhaustion, exercise at 80 W, and efficiency.
| Wmax (W) | 187.4 ± 28.8 | 207.1 ± 32.2 | 356.6 ± 40.5 | 370.1 ± 42.2 | 0.000 | 0.000 | 0.019 |
| Wmax·limb mean mass−1 (W·kg−1) | 22.91 ± 2.90 | 25.31 ± 2.60 | 17.21 ± 1.41 | 17.81 ± 1.53 | 0.000 | 0.000 | 0.000 |
| T lim (s) | 502.1 ± 86.5 | 561.3 ± 96.6 | 355.9 ± 48.6 | 372.1 ± 50.6 | 0.000 | 0.000 | 0.000 |
| HR (beats·min−1) | 186.0 ± 10.1 | 187.8 ± 8.4 | 187.4 ± 9.3 | 188.8 ± 7.9 | 0.272 | 0.209 | 0.801 |
| VO2peak (L·min−1) | 3.15 ± 0.48 | 3.46 ± 0.48 | 3.88 ± 0.47 | 4.12 ± 0.46 | 0.000 | 0.000 | 0.184 |
| VO2peak·Wmax−1 (mL·min−1·W−1) | 16.8 ± 1.2 | 16.8 ± 1.2 | 39.6 ± 6.1 | 40.2 ± 3.9 | 0.705 | 0.000 | 0.645 |
| VO2peak·lean mass−1 (mL·min−1·kg−1) | 383.8 ± 44.8 | 422.4 ± 36.5 | 186.8 ± 12.8 | 198.0 ± 15.7 | 0.000 | 0.000 | 0.000 |
| VCO2 (L·min−1) | 3.50 ± 0.55 | 3.91 ± 0.59 | 4.57 ± 0.65 | 5.08 ± 0.85 | 0.000 | 0.000 | 0.401 |
| V | 121.5 ± 19.6 | 136.1 ± 20.5 | 153.4 ± 30.5 | 165.0 ± 21.1 | 0.001 | 0.000 | 0.653 |
| RER | 1.15 ± 0.06 | 1.16 ± 0.04 | 1.19 ± 0.11 | 1.25 ± 0.11 | 0.163 | 0.028 | 0.161 |
| RR (breaths·min−1) | 55.7 ± 8.4 | 58.9 ± 8.2 | 54.4 ± 12.1 | 58.2 ± 5.7 | 0.055 | 0.626 | 0.825 |
| Vt (L) | 2.44 ± 0.41 | 2.46 ± 0.37 | 3.18 ± 0.56 | 3.08 ± 0.42 | 0.507 | 0.000 | 0.137 |
| V | 38.8 ± 4.8 | 39.7 ± 5.2 | 39.6 ± 6.1 | 40.2 ± 3.9 | 0.371 | 0.532 | 0.840 |
| V | 34.8 ± 3.9 | 35.1 ± 5.0 | 34.0 ± 6.8 | 33.0 ± 5.0 | 0.727 | 0.173 | 0.400 |
| Blood lactate 2.5 min (mM) | 9.99 ± 2.05 | 10.95 ± 1.71 | 10.39 ± 2.43 | 10.76 ± 2.04 | 0.049 | 0.771 | 0.147 |
| HR (beats·min−1) | 152.20 ± 21.40 | 135.60 ± 17.06 | 132.13 ± 17.72 | 129.73 ± 14.71 | 0.000 | 0.011 | 0.001 |
| VO2 (L·min−1) | 1.94 ± 0.22 | 1.75 ± 0.15 | 2.06 ± 0.33 | 2.04 ± 0.30 | 0.008 | 0.014 | 0.010 |
| VO2·lean mass−1 (mL·min−1·kg−1) | 238.78 ± 29.08 | 216.38 ± 26.06 | 99.12 ± 12.46 | 98.12 ± 11.63 | 0.009 | 0.000 | 0.007 |
| VCO2 (L·min−1) | 1.95 ± 0.18 | 1.73 ± 0.14 | 1.94 ± 0.41 | 1.90 ± 0.30 | 0.002 | 0.355 | 0.033 |
| V | 57.99 ± 4.81 | 51.10 ± 5.78 | 51.11 ± 13.26 | 50.37 ± 9.53 | 0.010 | 0.138 | 0.015 |
| RER | 1.01 ± 0.05 | 0.99 ± 0.04 | 0.94 ± 0.07 | 0.93 ± 0.05 | 0.212 | 0.001 | 0.668 |
| RR (breaths·min−1) | 28.9 ± 4.2 | 28.4 ± 5.6 | 24.4 ± 5.1 | 24.8 ± 4.3 | 0.861 | 0.000 | 0.460 |
| V | 2.04 ± 0.29 | 1.85 ± 0.35 | 2.13 ± 0.47 | 2.06 ± 0.32 | 0.001 | 0.019 | 0.309 |
| V | 30.0 ± 3.2 | 29.3 ± 3.6 | 24.7 ± 3.4 | 24.7 ± 2.6 | 0.397 | 0.000 | 0.128 |
| V | 29.8 ± 2.0 | 29.5 ± 3.0 | 26.2 ± 2.5 | 26.6 ± 2.6 | 0.953 | 0.000 | 0.226 |
| Blood lactate (mM) | 4.84 ± 1.32 | 4.45 ± 1.36 | 2.48 ± 1.29 | 2.26 ± 0.72 | 0.101 | 0.000 | 0.652 |
| Intensity (W) | 67.5 ± 11.1 | 67.5 ± 11.1 | 120.3 ± 24.4 | 120.3 ± 24.4 | |||
| Gross efficiency | 0.11 ± 0.01 | 0.11 ± 0.01 | 0.14 ± 0.02 | 0.13 ± 0.02 | 0.004 | 0.000 | 0.000 |
| Delta efficiency | 0.17 ± 0.02 | 0.17 ± 0.02 | 0.24 ± 0.04 | 0.24 ± 0.05 | 0.426 | 0.000 | 0.716 |
Values are means ± SD; n = 16 subjects; Wmax (W), Peak power output during the incremental exercise test; T lim, duration of the incremental exercise test (s); HR, Heart rate; VO2peak, Peak oxygen uptake during the incremental exercise test; VCO2, CO2 production; VE, Pulmonary ventilation; RER, Respiratory exchange ratio; RR, Respiratory rate; Vt, Tidal volume;
P < 0.05 compared corresponding Pre-training value.
Effects of six sessions of sprint interval training on ergoespirometric variables and performance during a time-trial lasting for 5 min.
| Power (W) | 118.2 ± 25.9 | 134.1 ± 29.8 | 202.0 ± 42.2 | 225.8 ± 39.6 | 0.000 | 0.000 | 0.740 |
| HR (beats·min−1) | 155.4 ± 10.3 | 156.1 ± 12.9 | 160.7 ± 11.4 | 164.4 ± 10.3 | 0.333 | 0.000 | 0.274 |
| % VO2peak | 67.7 ± 5.7 | 68.5 ± 8.4 | 77.3 ± 6.8 | 79.0 ± 5.4 | 0.490 | 0.000 | 0.639 |
| VO2 (L·min−1) | 2.13 ± 0.37 | 2.37 ± 0.47 | 3.01 ± 0.51 | 3.25 ± 0.41 | 0.002 | 0.000 | 0.960 |
| VCO2 (L·min−1) | 2.06 ± 0.39 | 2.33 ± 0.47 | 2.87 ± 0.59 | 3.15 ± 0.42 | 0.012 | 0.000 | 0.888 |
| V | 75.8 ± 18.7 | 81.3 ± 19.7 | 94.3 ± 27.8 | 101.4 ± 20.4 | 0.183 | 0.000 | 0.646 |
| RER | 0.95 ± 0.07 | 0.97 ± 0.05 | 0.92 ± 0.07 | 0.95 ± 0.04 | 0.227 | 0.034 | 0.696 |
| RR (breaths·min−1) | 37.4 ± 8.0 | 39.8 ± 8.8 | 34.3 ± 8.4 | 35.8 ± 7.0 | 0.238 | 0.026 | 0.416 |
| V | 2.05 ± 0.45 | 2.07 ± 0.48 | 2.71 ± 0.54 | 2.82 ± 0.41 | 0.275 | 0.000 | 0.153 |
| V | 35.5 ± 5.6 | 34.3 ± 5.1 | 31.0 ± 6.1 | 31.1 ± 4.3 | 0.634 | 0.001 | 0.135 |
| V | 36.7 ± 4.3 | 34.9 ± 4.1 | 32.7 ± 5.2 | 32.1 ± 4.2 | 0.179 | 0.003 | 0.243 |
| Blood Lactate (mM) | 8.96 ± 1.76 | 8.88 ± 1.93 | 10.57 ± 2.37 | 10.80 ± 2.04 | 0.877 | 0.000 | 0.544 |
| Fat oxidation (mg·min−1) | 161.1 ± 146.8 | 110.6 ± 126.4 | 277.2 ± 224.2 | 185.5 ± 169.8 | 0.159 | 0.017 | 0.614 |
The values presented are means ± SD for the 5-min time-trial (n = 16); HR, Heart rate; VO2, mean oxygen uptake; VCO2, mean CO2 production; VE, mean pulmonary ventilation; RER, mean respiratory exchange ratio; RR, mean respiratory rate; Vt, mean tidal volume;
P < 0.05 compared to the corresponding Pre-training value.
Effects of six sessions of arm-cranking and leg pedaling sprint interval training on Wingate test performance and ergospirometric variables.
| PPO (W) | First | 615.8 ± 89.8 | 659.3 ± 80.7 | 871.8 ± 84.9 | 902.8 ± 84.4 | 0.001 | 0.000 | 0.056 | 0.002 | 0.006 | 0.000 | 0.123 |
| Second | 561.5 ± 80.8 | 633.0 ± 85.4 | 808.8 ± 119.8 | 866.6 ± 106.9 | ||||||||
| PPO·lean mass−1 (W·kg−1) | First | 74.8 ± 10.6 | 80.3 ± 6.7 | 42.1 ± 3.4 | 43.5 ± 3.4 | 0.001 | 0.000 | 0.046 | 0.002 | 0.006 | 0.000 | 0.091 |
| Second | 68.0 ± 6.7 | 77.1 ± 7.1 | 39.0 ± 5.2 | 41.7 ± 4.4 | ||||||||
| MPO (W) | First | 431.6 ± 63.9 | 460.9 ± 61.1 | 607.6 ± 69.1 | 626.7 ± 65.2 | 0.000 | 0.000 | 0.403 | 0.000 | 0.000 | 0.000 | 0.332 |
| Second | 381.9 ± 52.4 | 413.4 ± 63.0 | 533.4 ± 62.9 | 567.0 ± 62.7 | ||||||||
| MPO·lean mass−1 (W·kg−1) | First | 52.4 ± 6.8 | 56.0 ± 3.5 | 29.2 ± 1.9 | 30.1 ± 1.4 | 0.000 | 0.000 | 0.324 | 0.000 | 0.000 | 0.000 | 0.265 |
| Second | 46.2 ± 3.8 | 50.3 ± 5.3 | 25.6 ± 1.4 | 27.2 ± 1.3 | ||||||||
| O2 demand (L·min−1) | First | 7.99 ± 1.20 | 8.14 ± 1.36 | 7.82 ± 1.07 | 8.41 ± 0.82 | 0.016 | 0.004 | 0.226 | 0.000 | 0.000 | 0.671 | 0.207 |
| Second | 7.12 ± 0.86 | 7.35 ± 1.33 | 7.00 ± 0.99 | 7.70 ± 0.77 | ||||||||
| O2 demand·kg BW−1 (ml·kg−1·min−1) | First | 102.1 ± 14.0 | 104.0 ± 12.8 | 99.8 ± 10.9 | 108.1 ± 12.4 | 0.009 | 0.004 | 0.226 | 0.000 | 0.000 | 0.671 | 0.207 |
| Second | 90.7 ± 6.6 | 94.0 ± 13.7 | 89.3 ± 10.5 | 98.9 ± 10.7 | ||||||||
| O2demand·lean mass−1 (ml·min−1) | First | 973.2 ± 157.7 | 988.0 ± 99.0 | 376.0 ± 35.2 | 405.2 ± 38.8 | 0.009 | 0.000 | 0.334 | 0.000 | 0.000 | 0.000 | 0.306 |
| Second | 864.8 ± 96.1 | 893.4 ± 116.9 | 336.4 ± 32.2 | 370.7 ± 33.3 | ||||||||
| VO2 (L) | First | 0.94 ± 0.21 | 1.54 ± 0.30 | 1.85 ± 0.23 | 1.97 ± 0.17 | 0.000 | 0.000 | 0.000 | 0.000 | 0.003 | 0.000 | 0.000 |
| Second | 1.24 ± 0.18 | 1.78 ± 0.21 | 2.00 ± 0.20 | 2.11 ± 0.20 | ||||||||
| VO2·kg BW−1 (ml·kg−1·min−1) | First | 12.0 ± 2.3 | 19.7 ± 3.4 | 23.6 ± 2.7 | 25.3 ± 1.8 | 0.000 | 0.000 | 0.000 | 0.000 | 0.003 | 0.000 | 0.000 |
| Second | 15.9 ± 2.0 | 22.8 ± 2.0 | 25.5 ± 2.1 | 27.1 ± 1.8 | ||||||||
| VO2·lean mass−1 (ml·kg−1·min−1) | First | 113.7 ± 20.0 | 188.1 ± 34.8 | 88.9 ± 7.7 | 95.1 ± 6.7 | 0.000 | 0.000 | 0.000 | 0.000 | 0.003 | 0.000 | 0.000 |
| Second | 150.7 ± 17.1 | 216.8 ± 18.3 | 96.2 ± 5.9 | 101.4 ± 4.0 | ||||||||
| V | First | 45.5 ± 11.9 | 59.5 ± 19.0 | 92.0 ± 28.9 | 91.9 ± 20.3 | 0.022 | 0.000 | 0.001 | 0.000 | 0.000 | 0.000 | 0.001 |
| Second | 77.3 ± 12.6 | 104.2 ± 17.4 | 136.4 ± 24.5 | 135.4 ± 21.7 | ||||||||
| RR (breaths·min−1) | First | 40.7 ± 12.6 | 42.2 ± 18.1 | 64.8 ± 21.1 | 57.7 ± 18.0 | 0.735 | 0.001 | 0.523 | 0.035 | 0.237 | 0.002 | 0.324 |
| Second | 47.5 ± 10.5 | 49.0 ± 7.5 | 55.0 ± 12.1 | 53.7 ± 9.9 | ||||||||
| Tidal volume (L) | First | 1.17 ± 0.29 | 1.50 ± 0.32 | 1.47 ± 0.30 | 1.64 ± 0.24 | 0.000 | 0.000 | 0.001 | 0.000 | 0.000 | 0.000 | 0.005 |
| Second | 1.68 ± 0.33 | 2.13 ± 0.22 | 2.52 ± 0.37 | 2.55 ± 0.36 | ||||||||
| O2 deficit (L) | First | 3.05 ± 0.58 | 2.53 ± 0.64 | 2.07 ± 0.43 | 2.23 ± 0.32 | 0.385 | 0.000 | 0.001 | 0.000 | 0.000 | 0.001 | 0.003 |
| Second | 2.32 ± 0.38 | 1.90 ± 0.51 | 1.50 ± 0.39 | 1.74 ± 0.27 | ||||||||
| O2 deficit·MPO−1 (mL·W−1) | First | 7.10 ± 0.98 | 5.45 ± 0.96 | 3.39 ± 0.54 | 3.56 ± 0.44 | 0.058 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| Second | 6.11 ± 0.92 | 4.55 ± 0.75 | 2.79 ± 0.53 | 3.07 ± 0.44 | ||||||||
| O2 deficit·lean mass−1 (mL·Kg−1) | First | 0.88 ± 0.19 | 0.67 ± 0.12 | 0.16 ± 0.03 | 0.17 ± 0.03 | 0.057 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.001 |
| Second | 0.75 ± 0.16 | 0.56 ± 0.10 | 0.13 ± 0.03 | 0.15 ± 0.03 | ||||||||
The values presented are means ± SD (n = 13, oxygen deficit could not be computed in all conditions in 3 subjects). W1, First Wingate test; W2, Second Wingate test; PPO, Peak power output; MPO, Mean power output; BW, Body weight; VO2, O2 consumption; Accumulated VO2, Total VO2 during the 30-s Wingate test; VE, Pulmonary ventilation; RR, Respiratory rate;
P < 0.05 compared to the corresponding Pre value;
P < 0.05 compared to the Pre value for the arms;
P < 0.05 compared to the arms post;
P < 0.05 compared to W1.
Lean mass, muscle morphology, and muscle enzymes before and after 7 sessions of sprint training.
| Lean mass (g) | 8223 ± 1111 | 8194 ± 1032 | 20769 ± 2015 | 20824 ± 2057 | 0.810 | 0.000 | 0.407 |
| Type I (%) | 42.3 ± 9.3 | 31.0 ± 5.7 | 51.9 ± 3.2 | 47.7 ± 11.4 | 0.116 | 0.010 | 0.180 |
| Type IIa (%) | 56.9 ± 9.9 | 68.2 ± 6.2 | 46.5 ± 2.6 | 50.4 ± 10.2 | 0.119 | 0.004 | 0.260 |
| Type IIx (%) | 2.5 ± 1.8 | 1.5 ± 1.2 | 2.1 ± 2.6 | 10.6 | |||
| Type II (IIa+IIx) (%) | 57.7 ± 9.3 | 69.0 ± 5.7 | 47.9 ± 3.4 | 52.2 ± 11.5 | 0.112 | 0.010 | 0.194 |
| CSA I (μm2) | 5232 ± 914 | 5729 ± 1191 | 4941 ± 473 | 4781 ± 669 | 0.572 | 0.163 | 0.223 |
| CSA-IIa (μm2) | 8234 ± 1978 | 8102 ± 2722 | 6030 ± 707 | 5684 ± 1226 | 0.585 | 0.016 | 0.669 |
| CSA-IIx (μm2) | 5929 ± 54 | 5701 ± 601 | 5873 ± 766 | 4044 | |||
| CSA-II (IIa+IIx) (μm2) | 8150 ± 1929 | 7983 ± 2795 | 5870 ± 837 | 5471 ± 979 | 0.492 | 0.024 | 0.757 |
| MHC I | 26.4 ± 9.0 | 24.7 ± 7.3 | 44.4 ± 10.7 | 48.9 ± 11.4 | 0.452 | 0.000 | 0.037 |
| MHC IIa | 67.8 ± 14.4 | 71.8 ± 8.9 | 52.8 ± 9.8 | 48.8 ± 11.4 | 0.996 | 0.000 | 0.061 |
| MHC IIx | 5.8 ± 9.8 | 3.5 ± 5.8 | 2.9 ± 3.0 | 2.3 ± 2.5 | 0.274 | 0.164 | 0.524 |
| Capillaries·mm−2 | 451 ± 114 | 477 ± 144 | 557 ± 139 | 618 ± 171 | 0.004 | 0.001 | 0.234 |
| Capillaries·fiber−1 | 2.94 ± 0.72 | 3.38 ± 1.12 | 2.95 ± 0.83 | 3.23 ± 0.69 | 0.002 | 0.754 | 0.596 |
| Glycogen (mmol·kg−1) | 422.6 ± 76.7 | 455.0 ± 47.7 | 428.5 ± 95.3 | 433.5 ± 70.8 | 0.182 | 0.816 | 0.576 |
| CS (μmol·g dw−1·min−1) | 33.7 ± 17.0 | 42.1 ± 13.6 | 71.9 ± 18.7 | 86.4 ± 18.0 | 0.005 | 0.000 | 0.295 |
| HAD (μmol·g dw−1·min−1) | 58.7 ± 16.8 | 49.2 ± 15.1 | 96.2 ± 19.1 | 112.0 ± 25.8 | 0.206 | 0.000 | 0.006 |
CSA, cross-sectional area; MHC, myosin heavy chain; CS, citrate synthase; HAD, hydroxyacyl-CoA-dehydrogenase; dw, dry weight;
P < 0.05 compared to Pre-training;
n = 6;
n = 15.
Multiple regression models predicting time-trail performance during arm cranking and leg pedaling before and the after training intervention.
| 1 | (Constant) | −52.42 | 46.82 | −1.1 | 0.292 | 0.62 | 18.3 | 1,2,5,7,8,10,11 | ||
| VO2peak | 53.51 | 14.02 | 0.786 | 3.8 | 0.004 | |||||
| 2 | (Constant) | 40.09 | 47.50 | 0.8 | 0.423 | 0.812 | 13.6 | |||
| VO2peak | 51.00 | 10.48 | 0.749 | 4.9 | 0.001 | |||||
| Lac INCR | −8.08 | 2.82 | −0.442 | −2.9 | 0.021 | |||||
| 3 | (Constant) | −45.47 | 47.65 | −1.0 | 0.372 | 0.908 | 10.2 | |||
| VO2peak | 47.62 | 7.95 | 0.7 | 6.0 | 0.001 | |||||
| Lac INCR | −6.41 | 2.20 | −0.35 | −2.9 | 0.023 | |||||
| Delta Efficiency | 478.82 | 177.48 | 0.328 | 2.7 | 0.031 | |||||
| 4 | (Constant) | −162.50 | 29.91 | −5.4 | 0.002 | 0.985 | 4.5 | |||
| VO2peak | 47.50 | 3.50 | 0.698 | 13.6 | 0.000 | |||||
| Lac INCR | −4.97 | 1.00 | −0.271 | −4.9 | 0.003 | |||||
| Delta Efficiency | 606.05 | 81.50 | 0.415 | 7.4 | 0.000 | |||||
| Gross Efficiency | 763.55 | 139.13 | 0.295 | 5.5 | 0.002 | |||||
| 5 | (Constant) | −183.20 | 16.45 | −11.1 | 0.000 | 0.996 | 2.3 | |||
| VO2peak | 40.75 | 2.46 | 0.599 | 16.6 | 0.000 | |||||
| Lac INCR | −2.80 | 0.74 | −0.153 | −3.8 | 0.013 | |||||
| Delta Efficiency | 714.72 | 50.19 | 0.49 | 14.2 | 0.000 | |||||
| Gross Efficiency | 925.12 | 82.76 | 0.357 | 11.2 | 0.000 | |||||
| MHC I | −0.52 | 0.13 | −0.187 | −4.1 | 0.009 | |||||
| 1 | (Constant) | −94.15 | 40.63 | −2.3 | 0.054 | 0.827 | 16.0 | 1,2,4,5,6,7,8,9,11 | ||
| VO2peak | 65.34 | 11.28 | 0.91 | 5.8 | 0.001 | |||||
| 2 | (Constant) | −193.80 | 39.41 | −4.9 | 0.003 | 0.94 | 10.2 | |||
| VO2peak | 63.46 | 7.21 | 0.884 | 8.8 | 0.000 | |||||
| %VO2peak | 1.17 | 0.35 | 0.336 | 3.4 | 0.015 | |||||
| 3 | (Constant) | −205.46 | 28.34 | −7.2 | 0.001 | 0.975 | 7.2 | |||
| VO2peak | 79.02 | 7.83 | 1.1 | 10.1 | 0.000 | |||||
| %VO2peak | 1.14 | 0.25 | 0.327 | 4.6 | 0.006 | |||||
| Mean Oxygen Deficit | −18.15 | 6.91 | −0.285 | −2.6 | 0.047 | |||||
| 1 | (Constant) | −45.12 | 81.15 | −0.6 | 0.593 | 0.55 | 33.6 | 1,2,3,4,5,6,7,8,9,10,11 | ||
| VO2peak | 63.26 | 20.38 | 0.739 | 3.1 | 0.015 | |||||
| 1 | (Constant) | −88.332 | 49.447 | −1.786 | 0.112 | 0.843 | 18.0 | 1,2,3,4,6,7,8,9,10,11 | ||
| VO2peak | 76.932 | 11.733 | 0.918 | 6.557 | 0 | |||||
| 2 | (Constant) | −211.027 | 44.264 | −4.767 | 0.002 | |||||
| VO2peak | 89.916 | 7.948 | 1.073 | 11.313 | 0 | 0.949 | 11.0 | |||
| HAD | 0.609 | 0.161 | 0.36 | 3.795 | 0.007 | |||||
Variables code: 1, Capillaries; 2, Citrate synthase activity in mmol·kg.
Figure 3Cardiorespiratory and ergometric responses to a 5-min time-trial before and after 6 sessions of sprint interval training during a 2-week period. (A) Power output; (B) oxygen uptake (VO2); (C) Ventilatory equivalent for oxygen (VE/VO2); (D) Ventilatory equivalent for carbon dioxide (VE/VCO2); (E) heart rate; (F) respiratory exchange ratio (RER); n = 16.